John Tatlock

495 total citations
10 papers, 280 citations indexed

About

John Tatlock is a scholar working on Infectious Diseases, Molecular Biology and Hepatology. According to data from OpenAlex, John Tatlock has authored 10 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in John Tatlock's work include HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (4 papers) and Click Chemistry and Applications (2 papers). John Tatlock is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (4 papers) and Click Chemistry and Applications (2 papers). John Tatlock collaborates with scholars based in United States. John Tatlock's co-authors include Stephanie T. Shi, Angelica Linton, Cristina Lewis, Heather Skor, Sadayappan V. Rahavendran, Jim Nonomiya, Luis Javier González, Michael J. Hickey, Xiu Yu and Hans E. Parge and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

John Tatlock

9 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Tatlock United States 7 152 139 87 86 72 10 280
Barbara Pacini Italy 8 163 1.1× 191 1.4× 104 1.2× 110 1.3× 89 1.2× 9 330
Lucille L’Heureux Canada 9 164 1.1× 169 1.2× 112 1.3× 94 1.1× 66 0.9× 9 327
Kenny Simmen Belgium 7 128 0.8× 99 0.7× 99 1.1× 96 1.1× 121 1.7× 8 327
John P. Maxwell United States 8 212 1.4× 107 0.8× 127 1.5× 154 1.8× 79 1.1× 23 409
Steven R. Mathieu United States 6 88 0.6× 116 0.8× 85 1.0× 66 0.8× 72 1.0× 8 255
Immacolata Conte Italy 8 121 0.8× 96 0.7× 62 0.7× 82 1.0× 132 1.8× 10 282
Sherie Masse United States 12 201 1.3× 170 1.2× 75 0.9× 119 1.4× 117 1.6× 16 355
Shintaro Hirashima Japan 8 142 0.9× 99 0.7× 76 0.9× 71 0.8× 255 3.5× 8 428
Keith Pietropaolo United States 12 194 1.3× 211 1.5× 67 0.8× 190 2.2× 34 0.5× 33 370
Frantz Victor United States 11 83 0.5× 96 0.7× 127 1.5× 59 0.7× 237 3.3× 15 400

Countries citing papers authored by John Tatlock

Since Specialization
Citations

This map shows the geographic impact of John Tatlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Tatlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Tatlock more than expected).

Fields of papers citing papers by John Tatlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Tatlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Tatlock. The network helps show where John Tatlock may publish in the future.

Co-authorship network of co-authors of John Tatlock

This figure shows the co-authorship network connecting the top 25 collaborators of John Tatlock. A scholar is included among the top collaborators of John Tatlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Tatlock. John Tatlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Qiu, Luping, Kymberly K. Levine, K.S. Gajiwala, et al.. (2018). Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers. PLoS ONE. 13(6). e0198374–e0198374. 16 indexed citations
2.
Kung, Pei‐Pei, Buwen Huang, Luke R. Zehnder, et al.. (2015). SAH derived potent and selective EZH2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(7). 1532–1537. 18 indexed citations
5.
Shi, Stephanie T., Jim Nonomiya, Sadayappan V. Rahavendran, et al.. (2009). Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrobial Agents and Chemotherapy. 53(6). 2544–2552. 58 indexed citations
6.
Tatlock, John. (2008). Principles and Practice of Life Insurance. 1 indexed citations
7.
Li, Hui, Angelica Linton, John Tatlock, et al.. (2007). Allosteric Inhibitors of Hepatitis C Polymerase:  Discovery of Potent and Orally Bioavailable Carbon-Linked Dihydropyrones. Journal of Medicinal Chemistry. 50(17). 3969–3972. 26 indexed citations
8.
Li, Hui, John Tatlock, Angelica Linton, et al.. (2006). Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(18). 4834–4838. 44 indexed citations
9.
Kalish, Vincent J., Stephen W. Kaldor, Bhasker V. Shetty, et al.. (1995). ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS. European Journal of Medicinal Chemistry. 30. 201s–214s. 21 indexed citations
10.
Varney, Michael D., Krzysztof Appelt, Vincent J. Kalish, et al.. (1994). ChemInform Abstract: Crystal Structure Based Design and Synthesis of Novel C‐Terminal Inhibitors of HIV Protease.. ChemInform. 25(51). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026